Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal vaccination response as predictor of successful TKI discontinuation in CML
NL-OMON55091Completed
- Sponsor
- Albert Schweitzer Hospital
- Start
- Jan 2021
- Countries
- 1
01
Overview
Open-label trial in chronic myelogenous leukemia (CML), sponsored by Albert Schweitzer Hospital. Started Jan 2021; status: completed.
02
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on NL-OMON55091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55091.